| Bioactivity | Heptadecan-9-yl 8-((6-(decyloxy)-6-oxohexyl)(2-hydroxyethyl)amino)octanoate can be used in lipid nanoparticles (LNP) delivery systems for mRNA vaccine delivery[1]. |
| Name | Heptadecan-9-yl 8-((6-(decyloxy)-6-oxohexyl)(2-hydroxyethyl)amino)octanoate |
| CAS | 2714482-26-3 |
| Formula | C43H85NO5 |
| Molar Mass | 696.14 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Packer Meredith, et al. Lipid nanoparticle compositions and methods of formulating the same. Patent. EP4046629. |
Heptadecan-9-yl 8-((6-(decyloxy)-6-oxohexyl)(2-hydroxyethyl)amino)octanoate
CAS: 2714482-26-3 F: C43H85NO5 W: 696.14
Heptadecan-9-yl 8-((6-(decyloxy)-6-oxohexyl)(2-hydroxyethyl)amino)octanoate can be used in lipid nanoparticles (LNP) del
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.